Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR as adjunct in Generalized Anxiety Disorder
NCT00534599Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in generalized anxiety disorder (GAD), sponsored by AstraZeneca. Started Aug 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00534599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534599.